
LAIs Tied to Lower Relapse, Mortality Risk in Schizophrenia
Oct 16, 2025 · Long-acting injectable antipsychotics are linked to a lower risk for disease relapse and mortality than oral antipsychotics in adults with schizophrenia, a new study shows.
Metoclopramide in the Treatment of Diabetic Gastroparesis
Acute Dystonic Reactions Acute dystonic reactions are the most frequent extrapyramidal side effects (EPS) from metoclopramide and typically occur within 24–48 h of initiating treatment, thus ...
Forget the Tremor: These Symptoms Come First in Parkinson’s
Jun 10, 2025 · It often appears alongside other signs like a softer, monotone voice or reduced arm swing while walking — both early signs of extrapyramidal dysfunction.
Untreated Tardive Dyskinesia Hinders Use of Antipsychotics
Jul 29, 2024 · Tardive dyskinesia, often underdiagnosed and undertreated, hinders patient adherence to antipsychotics, affecting mental health treatment and caregivers' well-being, reports Dr Daniel …
Treatment Considerations for Psychiatric Syndromes Associated with …
Another important consideration is HIV-infected patients' increased sensitivity to antipsychotic-induced extrapyramidal symptoms, thought to be related to the damage to basal ganglia observed in ...
'Impressive' New Data on Novel Schizophrenia Hopeful KarXT
May 8, 2024 · The novel investigational antipsychotic KarXT was effective and well tolerated in adults with schizophrenia experiencing acute psychosis in a second phase 3 trial.
New Management Approaches for Gastroparesis - Page 4 - Medscape
It has the advantage of either parenteral (including subcutaneous) or oral dosing, but side effects including extrapyramidal reactions are not uncommon. [43] Tardive dyskinesia represents a ...
Long-Acting Injectables Curb Schizophrenia Readmission
Feb 7, 2024 · Patients with schizophrenia discharged on an LAI antipsychotic had significantly lower 30-day psychiatric readmission rates than those sent home with an oral antipsychotic.
Antipsychotics and Akathisia - Medscape
Dec 29, 2008 · The potential for the development of extrapyramidal side effects is better understood now that atypical antipsychotic medications have been used prospectively and in larger patient populations.
Is CBD Effective for Psychosis? New Study Aims to Find Out
Feb 18, 2025 · CBD has shown promise as a treatment for psychosis in small studies and case reports. A large, international trial launching in April aims to put those findings to the test.